In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Superior Vena Cava Syndrome with Retropharyngeal Edema as a Complication of Ventriculoatrial Shunt

    Final Number:

    Daniel Gaudin MD, PhD; Mohammed Al-Natour MD; Pouya Entezami BS, MD; Munier Nazzal MD, FRCS; Andrew B Casabianca MD

    Study Design:

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Ventriculoatrial (VA) shunting for the treatment of hydrocephalus is a common neurosurgical procedure. Complications include shunt failure, infection, and cardiovascular compromise. Superior vena cava syndrome secondary to VA shunting is a devastating complication which has rarely been reported.

    Methods: A 37 year-old female with history of Dandy-Walker malformation and congenital hydrocephalus managed by two shunts presented with progressive facial swelling, neck and bilateral upper extremity edema, dysphagia, and headache. Imaging on presentation demonstrated a retropharyngeal fluid collection compromising the airway, extensive venous collaterals in the upper mediastinum and paraspinal regions, a prominent azygous arch, and ventriculopleural catheter disruption. Further studies showed thrombosis of the catheter-bearing SVC and the azygous vein. Direct catheter thrombolysis using tissue plasminogen activator (tPA) was initiated, ultimately leading to resolution of thrombus burden in both vessels with remnant severe SVC stenosis at the catheter tip. Angioplasty and stenting were performed. Patient’s symptoms improved significantly following the procedures.

    Results: The etiology of our patient’s SVC thrombosis was believed to be multifactorial, including SVC stenosis secondary to long-term VA catheter implantation and recent OCP initiation. SVC syndrome results from disruption of blood flow through the SVC to the right atrium. There has been a significant increase in benign causes of SVC syndrome over the last two decades, thought to be mainly due to the increase in the use of indwelling central venous catheters and cardiac pacemakers.

    Conclusions: Though rare, SVC thrombosis as a consequence of VA shunting is a distressing complication which must be managed emergently.

    Patient Care: This research will help improve our ability to manage this potentially devastating complication of VA shunting.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Recognize SVC thrombosis as a potential complication of VA catheterization; 2) Identify the clinical symptomatology of SVC thrombosis due to presence of indwelling catheter; 3) Refresh their knowledge on the correct management of retropharyngeal edema due to SVC thrombosis, an uncommon presentation in Neurosurgery

    References: 1. Greenberg MS. Handbook of Neurosurgery. Seventh ed. Tampa, Florida: Greenberg Graphics, Inc.; 2010. 2. Vik A, Kumar S, Singh K, Hansen JB. [Local thrombolysis with stent implantation in a patient with vena cava superior syndrome]. Tidsskr Nor Laegeforen 2003;123:2049-50. 3. O'Shea PA. Inferior vena cava and hepatic vein thrombosis as a rare complication of ventriculoatrial shunt. Case report. J Neurosurg 1978;48:143-5. 4. Funaki B. Superior vena cava syndrome. Semin Intervent Radiol 2006;23:361-5. 5. Schechter MM. The superior vena cava syndrome. Am J Med Sci 1954;227:46-56. 6. Cardiopulmonary syndromes. National Cancer Institute, 2005. (Accessed 3/11/2015, 2015, at 7. Flounders JA. Oncology emergency modules: superior vena cava syndrome. Oncol Nurs Forum 2003;30:E84-90. 8. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984;2:961-9. 9. Klassen KP, Andrews NC, Curtis GM. Diagnosis and treatment of superior-vena-cava obstruction. AMA Arch Surg 1951;63:311-25. 10. Nieto AF, Doty DB. Superior vena cava obstruction: clinical syndrome, etiology, and treatment. Curr Probl Cancer 1986;10:441-84. 11. Parish JM, Marschke RF, Jr., Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981;56:407-13. 12. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37-42. 13. Chang CY, Lai YC, Chang SC. Superior vena cava syndrome related fluid collection in retropharyngeal space. QJM 2012;105:907-9. 14. Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg 2008;47:372-80.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy